Home » Topics » BioWorld Science

BioWorld Science
RSS

Zp Spv 3 K/S describes complement C3 inhibitors

Feb. 10, 2022

Customization of regulatory elements in hearing loss gene therapies using AAVAnc80 vectors

Feb. 10, 2022

Challenge Bioproducts synthesizes new PTGER4 ligands

Feb. 10, 2022

Reaction Biology presents new HDAC inhibitors

Feb. 10, 2022

Eccogene divulges new GLP-1R agonists

Feb. 10, 2022

Chinese researchers identify new CRBN modulators

Feb. 10, 2022

Anti-VISTA HMBD-002 antibody blocks VISTA-induced immunosuppression in preclinical models

Feb. 10, 2022

Researchers improve cisplatin-induced ototoxicity model

Feb. 10, 2022

TMID enzymes as potential antiviral targets for the treatment of HHV infections

Feb. 10, 2022

New drug combinations with synergistic inhibitory activity against SARS-CoV-2

Feb. 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...